V Sethuraman
University of North Carolina at Chapel Hill
6 Papers
52 Citations
V Sethuraman is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Chemistry & Fourier transform. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
V Sethuraman,Anthony J. Hickey +1 more
TL;DR: Delivery of dry powder formulations can be achieved by characterizing particle surfaces and predicting impact on dispersion through knowledge of particle surface properties, and an expression is proposed as a predictor of drug dispersion from carrier particles.
Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig
TL;DR: Aerosolized RPLGA reduced most measures of tuberculosis (TB) infection and is further evidence for the potential of inhaled aerosol therapy for the treatment of TB.
54
Signal Processing and Analysis Applied to Powder Behavior in a Rotating Drum
TL;DR: In this paper, a Fourier Transform power spectrum and phase space analysis of the angle of repose time series and avalanche size variability determination was used to distinguish between the flow properties of powders across material types.
16
Evaluation of preseparator performance for the 8-stage nonviable Andersen impactor
V Sethuraman,Anthony J. Hickey +1 more
TL;DR: The preseparator of an Andersen impactor with different coating treatments for a range of particle-size distributions was evaluated and pre separator coating was shown to influence performance and thereby estimates of particle size by intertial impaction.
Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study
Marja Puurunen,Jerry Vockley,Shawn L. Searle,Stephanie Sacharow,John A. Phillips,William S. Denney,Benjamin D. Goodlett,D. A. Wagner,L A Blankstein,Mary Castillo,Mark R. Charbonneau,Vincent M. Isabella,V Sethuraman,Richard J. Riese,Caroline B. Kurtz,Aoife M. Brennan +15 more
TL;DR: Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study is corrected.